The Impact of Lenalidomide, Bortezomib, and Dexamethasone Treatment on Health-Related Quality of Life in Transplant-Eligible Patients with Newly-Diagnosed Multiple Myeloma: Results from the IFM/DFCI 2009 Trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreThe Impact of Lenalidomide, Bortezomib, and Dexamethasone Treatment on Health-Related Quality of Life in Transplant-Eligible Patients with Newly-Diagnosed Multiple Myeloma: Results from the IFM/DFCI 2009 Trial
Type de publicationJournal Article
Year of Publication2018
AuteursRoussel M, Hebraud B, Hulin C, Perrot A, Caillot D, Macro M, Arnulf B, Belhadj K, Garderet L, Facon T, Guo S, Altincatal A, Dhanasiri S, Leleu X, Moreau P, Attal M
JournalBLOOD
Volume132
Date PublishedNOV 29
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood-2018-99-111477